Now let me compose the final review.

## Summary

This paper introduces HYPOGENEAGENT, an LLM-driven framework that uses gene-set functional annotations (GO hypotheses) to select clustering resolution parameters in single-cell and Perturb-seq analyses. The core novelty is closing the loop between clustering and annotation: instead of selecting resolution with biologically agnostic metrics (silhouette, modularity) and annotating post-hoc, HYPOGENEAGENT generates LLM-based GO hypotheses for each cluster, computes intra-cluster agreement (ICS) and inter-cluster distinctiveness (ICD), and selects the resolution that maximizes a combined Resolution Score. The paper benchmarks LLM configurations on 100 GOBP gene sets (Stage 1) and applies the pipeline to a single K562 Perturb-seq dataset (Stage 2).

## Strengths

- **Genuinely novel core idea.** The paper correctly identifies that resolution selection and functional annotation are currently decoupled, and proposes using LLM-generated functional annotations as a criterion for resolution selection — a framing no prior work has attempted (Section 1, lines 15–25). The idea of treating cluster annotation as an optimizable objective rather than a post-hoc descriptive step is creative and well-motivated.

- **Stage 1 GOBP benchmark is competently executed.** The systematic comparison of embedding methods (OpenAI, SapBERT, Nomic AI), prompt variants (general vs. hypothesis), temperature sensitivity, and multiple LLM backends (GPT-4o, GPT-o3, GPT-5, Gemini-2.0-flash, Gemini-2.5-pro) on 100 curated GOBP gene sets is a reasonable design-space exploration. The finding that GPT-o3 with the hypothesis prompt yields the best annotation quality (AUC=0.743) is empirically grounded and motivates the Stage 2 configuration.

- **Clean, modular method definition.** The separation into intra-cluster agreement (ICS), inter-cluster distinctiveness (ICD), and a weighted Resolution Score (Section 3.4) is well-structured and easy to understand. The pipeline from clustering → gene-signature extraction → LLM annotation → embedding → metric computation → resolution selection is clearly described.

## Weaknesses

### Fatal
None. The core idea is not fundamentally flawed; the issues are about insufficient validation.

### Major

- **No independent validation that the selected resolution is biologically superior.** The paper reports that HYPOGENEAGENT selects r=0.4 for GEX and r=0.5 for perturbation, and compares these against silhouette, modularity, and GO enrichment baselines. However, it never independently establishes what the *correct* resolution should be. The claim that the selected resolution "exhibits alignment with known pathway" (abstract) or "recovers known perturbation effects" (line 261) is asserted without any experiment that compares cluster composition, marker-gene recovery, or pathway reconstruction against a held-out ground truth — for example, a dataset with known cell-type labels, ground-truth perturbation targets, or a quantitative comparison of GO enrichment significance across resolutions. Without an external biological standard, the paper cannot demonstrate that the Resolution Score's choice is meaningfully better than alternatives. This is the most critical gap.

- **Evaluation on a single dataset from one cell type.** The entire Stage 2 evaluation uses one K562 CRISPRi Perturb-seq dataset (Replogle et al. 2022), a well-characterized immortalized cell line. The abstract and conclusion make broader claims about generalizability (e.g., "readily extends to multi-omics modalities," line 25; "a powerful, general-purpose tool," line 265) that the single-dataset evaluation cannot support. While the paper acknowledges this limitation in the conclusion (line 265), the central claims in the abstract and introduction are stated in general terms that outpace the evidence.

- **ICS and ICD measure LLM output self-consistency, not directly cluster biological quality.** ICS_k (line 75) is the mean cosine similarity between the LLM's top hypothesis for a cluster and its four other hypotheses for the same cluster — it measures whether the LLM generates similar text from a single gene list, not whether the cells within the cluster are biologically coherent. The paper states this "implies that the cluster is internally coherent and biologically robust" (line 75), but no experiment validates that high ICS corresponds to biologically meaningful cell groupings. Similarly, ICD measures whether the LLM generates different text for different clusters, which does not guarantee the differences are biologically correct. The Resolution Score inherits this gap; it incorporates no independent biological signal (e.g., known marker genes, pathway databases, experimental validation). This does not invalidate the approach, but the interpretative leap from "LLM self-consistency" to "biological coherence" is asserted rather than demonstrated.

### Minor

- **Weight w=1/3 is under-justified.** The paper states it was "chosen by a small grid search and found to give a stable ordering of resolutions across data sets" (line 79), but only one dataset was evaluated, making "across data sets" inaccurate. The paper acknowledges sensitivity to w in the perturbation analysis (line 237). No principled criterion for choosing w or evaluating robustness of the ranking to w is provided.

- **"Calibrated confidence scores" claim is unsupported.** The paper repeatedly refers to "calibrated confidence scores" (lines 9, 65, 114, 157, 217) but describes no calibration procedure (temperature scaling, Platt scaling, etc.). If these are raw LLM output probabilities, the term "calibrated" is misleading without evidence.

- **Clustering procedure is too thin in the main text.** Section 3.2 provides approximately 3 lines of description, deferring all details (number of PCs, k for kNN graph, marker-gene selection thresholds) to the appendix. The main text should contain enough detail for a reader to assess whether the clustering is reasonable.

- **No repeat runs or variance reporting for Stage 2.** The resolution-selection experiment uses a single LLM call per cluster per resolution. Given that LLM outputs are stochastic and Stage 1 shows the model is ~74% accurate (AUC), repeated runs with different random seeds are needed to assess whether the resolution ranking is stable across runs.

### Trivial

- **Cosine similarity range.** The paper states cosine similarity lies in [0, 1] (line 73). OpenAI text-embedding-3-large and most embedding models produce cosine similarities in [-1, 1]. The paper does not explain how negative values are handled or clamped.

## Nice-to-Haves

- Validate on additional datasets with known cell-type labels (e.g., PBMC or pancreas atlas) and check whether the Resolution Score-maximizing resolution also maximizes standard cell-type recovery metrics (ARI, purity).
- Ablate the LLM: replace LLM-generated hypotheses with a simpler text-similarity baseline (e.g., keyword overlap or TF-IDF from GO descriptions) to isolate the LLM's contribution.
- Report API costs to support claims of practical usability.
- Analyze the stability of the selected resolution under different random seeds for the LLM.

## Removed Points

These points from the input review were removed with justification:

- **"No code or reproducibility statement" / missing appendix details:** The appendix is stripped by the PDF parser; the paper references a "Data & code session" in the appendix which cannot be verified.
- **"Cost analysis missing":** Demoted to Nice-to-Have — useful but not a core flaw.
- **General criticism about AUC=0.743 being "far from perfect":** A measured performance level is not a weakness.
- **"The ICS and ICD convergence is expected by construction":** The paper's use of this as a sanity check is reasonable, not a flaw.
- **Requests for larger dataset or more model variety:** Already subsumed under the single-dataset weakness above.

## Novel Insights

The harsh review's observation that the ICS/ICD metrics fundamentally measure LLM output self-consistency rather than biological coherence is the most penetrating insight — it identifies a conceptual gap that the paper does not adequately address. This insight is captured above in the third Major weakness.

## Suggestions

1. **Add an independent biological validation experiment** — use a dataset with known cell-type labels (e.g., a well-annotated PBMC atlas) and quantitatively compare whether the Resolution Score-maximizing resolution also maximizes cell-type recovery against the ground truth.
2. **Add an LLM ablation** — replace the LLM-generated hypotheses with TF-IDF vectors from GO descriptions or keyword overlap and check whether the Resolution Score still distinguishes resolutions.
3. **Run multiple replicates of Stage 2** with different random seeds and report the distribution of selected resolutions.
4. **Clarify the cosine similarity normalization** and either correct the [0, 1] claim or explain how negative values are handled.
5. **Justify or remove the "calibrated" claim** for confidence scores.

## Score and Decision

The paper proposes a genuinely novel idea with a clean, well-structured method and a competent Stage 1 benchmark. However, the central empirical claim — that HYPOGENEAGENT selects biologically superior clustering resolutions — is not adequately supported. The evaluation is limited to a single dataset, there is no independent biological ground-truth validation, and the Resolution Score metrics measure LLM output consistency rather than directly measuring cluster biological quality. The substantial gap between the claimed contribution and the evidence presented prevents acceptance in the paper's current form.

MY FINAL SCORE: <score>4.0</score>
MY FINAL DECISION: <decision>Reject</decision>